Acute exacerbation of chronic hepatitis B virus infection in renal transplant patients

Lavanchy, 2004, Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures, J Viral Hepat, 11, 97, 10.1046/j.1365-2893.2003.00487.x CDC, 2001, Recommendations for preventing transmission of infections among chronic hemodialysis patients, MMWR Recomm Rep, 50, 1 Tsai, 2010, Hepatitis B virus infection and renal transplantation, World J Gastroenterol, 16, 3878, 10.3748/wjg.v16.i31.3878 Matos, 2007, Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection, Eur J Gastroenterol Hepatol, 19, 653, 10.1097/MEG.0b013e328133f091 Parfrey, 1985, The impact of renal transplantation on the course of hepatitis B liver disease, Transplantation, 39, 610, 10.1097/00007890-198506000-00007 Mathurin, 1999, Impact of hepatitis B and C virus on kidney transplantation outcome, Hepatology, 29, 257, 10.1002/hep.510290123 Hoofnagle, 2009, Reactivation of hepatitis B, Hepatology, 49, S156, 10.1002/hep.22945 Fornairon, 1996, The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection, Transplantation, 62, 297, 10.1097/00007890-199607270-00025 Murakami, 2006, Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience, Clin Transplant, 20, 351, 10.1111/j.1399-0012.2006.00490.x Savas, 2007, Clinical course of hepatitis B virus infection in renal allograft recipients, Dig Dis Sci, 52, 3440, 10.1007/s10620-006-9714-z Han, 2001, Results on preemptive or prophylactic treatment of lamivudine in HBsag (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with hbv recurrence, Transplantation, 71, 387, 10.1097/00007890-200102150-00008 Fontaine, 2000, HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients, Transplantation, 69, 2090, 10.1097/00007890-200005270-00020 Lau, 2000, Long-term therapy of chronic hepatitis B with lamivudine, Hepatology, 32, 828, 10.1053/jhep.2000.17912 Tur-Kaspa, 1986, Hepatitis B virus DNA contains a glucocorticoid-responsive element, Proc Natl Acad Sci U S A, 83, 1627, 10.1073/pnas.83.6.1627 Bedosa, 1996, An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group, Hepatology, 24, 289, 10.1002/hep.510240201 Lok, 1990, Acute exacerbations in chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology, J Hepatol, 10, 29, 10.1016/0168-8278(90)90069-4 Lee, 2001, Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients, Am J Kidney Dis, 38, 1074, 10.1053/ajkd.2001.28607 Yuen, 2003, A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy, Gut, 52, 416, 10.1136/gut.52.3.416 Dusheiko, 1983, Natural history of hepatitis B virus infection in renal transplant recipients-a fifteen-year follow-up, Hepatology, 3, 330, 10.1002/hep.1840030309 Degos, 1988, Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients, Gastroenterology, 94, 151, 10.1016/0016-5085(88)90623-3 Norder, 1989, High frequency of hepatitis B virus DNA in anti-HBe positive sera on longitudinal follow-up of patients with renal transplants and chronic hepatitis B, J Med Virol, 27, 322, 10.1002/jmv.1890270412 DePinho, 1984, Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans, Gastroenterology, 86, 162, 10.1016/0016-5085(84)90603-6 Gong, 1999, Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro, J Viral Hepat, 6, 229, 10.1046/j.1365-2893.1999.00163.x